Ledger.Open graph →
SEC Form D · filed December 10, 2013

Pinta Biotherapeutics, Inc

Offering
$18.0M
Sold
$18.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
BRISBANE, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (16)

Isaac Ciechanover · Brisbane, CAExec · DirectorJohn F. Mcgrath · Brisbane, CAExecJoel Marcus · Brisbane, CADirectorChristopher Haqq · Brisbane, CAExecBeth Seidenberg · Brisbane, CADirectorEckard Weber · Brisbane, CADirectorCarol Gallagher · Brisbane, CADirectorGad Soffer · Brisbane, CAExecAcademy Investment Management GP LLC · New York, NYExec · DirectorAcademy Investment Management LLC · New York, NYExecNicholas Stone · NEW YORK, NYDirectorAaron D. Grogan · Hendersonville, TNDirectorPeter J. Vitulli · Boulder, CODirectorDavid T. Cogut · Cos Cob, CTExecJames T. Hau · Boulder, COExecJoel Delman · Los Angeles, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗